🌱 KidneyEnergy.com

← brief for 2026-11-12 · Slowing decline

Monitoring Hyperkalemia Using Point-of-care AI-enabled ECG Device Among Patients With Chronic Kidney Disease Stages 3b-5

Trial No results yet Not peer reviewed

Key takeaways

This trial is starting to test a new heart monitor. It uses AI to check potassium levels in people with kidney disease. There are no results yet.

Who did this work

Run by Peking University First Hospital.
Sites: Peking University First Hospital · The First Affiliated Hospital of Guangxi Medical University · Hubei Provincial Hospital of TCM

Source

Trial · ClinicalTrials.gov, CKD recruiting · 2026-11-12
https://clinicaltrials.gov/study/NCT06901960